Clinical Trials Browser

Interventional × tivozanib × Gynecologic × Clear all

Bile Duct Neoplasms, Breast Neoplasms, Gallbladder Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vulvar Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT01853644 2021-10-12

TIVO

Phase 2 Completed

31 enrolled 12 charts

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Neoplasms, Recurrence

Clinical Trials

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

TIVO